GSK Pharma Q1 net down 23 per cent at Rs 72.27 cr

The company had posted a net profit of Rs 94.01 crore for the same period year ago, GlaxoSmithKline Pharmaceuticals said in a BSE filing.

By: PTI | New Delhi | Published: July 28, 2016 4:59:43 pm
GSK pharma growth, gsk growth, glaxosmithkline growth, glaxo smith kline growth, gsk pharma, pharma news, pharma growth GSK Pharmaceuticals on July 28 reported a 23.12 per cent fall in standalone net profit at Rs 72.27 crore for the June quarter

GlaxoSmithKline Pharmaceuticals on July 28 reported a 23.12 per cent fall in standalone net profit at Rs 72.27 crore for the June quarter, on account of increase in expenditure.

The company had posted a net profit of Rs 94.01 crore for the same period year ago, GlaxoSmithKline Pharmaceuticals said in a BSE filing.

However, standalone total income from operations of the company rose to Rs 705.33 crore during the quarter as against Rs 651.70 crore in the corresponding period of the previous fiscal.

“Sales and net profit have been adversely impacted by government mandatory price cuts during the quarter,” the company said.

Shares of GlaxoSmithKline Pharmaceuticals today closed 0.89 per cent down at Rs 3,347.50 per scrip on BSE.

For all the latest Business News, download Indian Express App